Financial Performance - The company reported unaudited revenue of RMB 1,062.5 million for the three months ended March 31, 2025, representing a 25.8% increase compared to RMB 844.3 million in the same period of 2024[5] - Net profit for the same period was RMB 33.2 million, a significant recovery from a net loss of RMB 37.8 million in the previous year[5] - Adjusted net profit reached RMB 57.9 million, compared to an adjusted net loss of RMB 18.8 million in the prior year[5] Business Growth - The company's F-end and B-end corporate health business revenue grew by 43% year-on-year, driven by innovative insurance and healthcare collaboration models[9] - The number of corporate clients served exceeded 2,100, with B-end paying users increasing by over 45% compared to the previous year[9] - The family doctor service has covered over 20 million users, while home care service users increased by 15% compared to the end of 2024[9] AI and Technology Integration - The company launched the AI assistant service "Ping An Xin Yi," which provides various online and offline medical support services, covering over 20 real medical scenarios[9] - The company plans to continue expanding the application of AI across various business scenarios to enhance the efficiency and quality of medical services[9]
平安好医生(01833) - 2025 Q1 - 季度业绩